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The authors report a case of malignant triton tumor of the spine, presenting at the thoracolumbar of a 70 year old 
gentleman, with back pain and left leg pain of two years duration. Unfortunately, 3 months after complete 
marginal resection, the patient developed local recurrence and seeding to the cauda equina, and died 10 months 
after diagnosis.  
Malignant triton tumor is a rare variant of malignant peripheral nerve sheath tumor that has rhabdomyoblastic 
differentiation [1]. The tumor originates from neural crest cells, and is a high grade sarcomatous lesion. Median 
age at presentation is 29 years, with male to female ratio 1.5:1. Overall survival at 18 months is around 45%, but 
adverse factors include incomplete resection, spinal involvement, size greater than 2cm, or association with 
neurofibromatosis. Accepted treatment is complete excision and post-operative radiotherapy, and sometimes 
chemotherapy. However, as in this case, resection of extensive spinal tumors is rarely complete.  
Although the authors did not perform a pre-operative CT-guided needle biopsy, the article raises the point that if 
a spine tumor looks unusual, it may be better to perform a biopsy or further staging investigations prior to 
removal, unless the patient presents as an emergency with rapid neurological progression. All spine tumors 
should be discussed in a multidisciplinary setting, with input from oncologists, spine surgeons, radiologists and 
pathologists. Particularly for unusual cases, multiprofessional discussion should increase the likelihood of 
choosing the most appropriate treatment, ensures co-ordination of treatment, and the delivery of consistent 
information to the patient [2].  Needle biopsies are generally safe, and with newer biopsy needles (thinner 
gauge, sheathed needles) they are less likely to be associated with tumor seeding along the biopsy tract [3]. The 
information obtained from the biopsy may alter the surgical plan or inform the consent process. Some tumors 
may respond better to primary chemotherapy or radiotherapy before surgery, or instead of surgery. Other tumors 
may have such a poor prognosis or high recurrence rate that surgery is not advisable, or is unlikely to change the 
natural history of the disease. Staging investigations are also important (for example, CT chest, CT Positron 
emission tomography, or whole body MRI) and will influence the surgical decision making and proposed extent 
of surgery. For example, it would be futile to perform a complex en bloc resection of spinal tumor in the 
presence of suspected metastatic disease.   
In the present case, more extensive surgery may not have changed the outcome, and marginal excision of the 
tumor was the likely treatment of choice. For intradural tumors, it is not possible to perform en bloc resection 
without sacrificing neurological function, and clear oncological clearance is seldom possible. The authors 
should be congratulated for highlighting the possibility of a rare aggressive tumor masquerading as a common 
benign tumor, and the possible management options should be considered at an early stage. If a pre-operative 
diagnosis of malignant tumor had been made by biopsy, consideration might be given to more extensive 
resection including T12 nerve root and adjacent vertebral bone and paraspinal soft tissues, or alternatively the 
option of a more palliative management plan, in some circumstances, would be appropriate. All potential 
options, as well as the recommended management plan, should be discussed with the patient during the consent 
process [4].     
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